Evidence supporting the use of: Resveratrol analogue
For the health condition: Arteriosclerosis

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Resveratrol analogues are used to support or treat arteriosclerosis based on some scientific evidence, though the strength of this evidence is limited and primarily preclinical. Resveratrol itself, a polyphenolic compound found in grapes and red wine, has been studied for its cardiovascular benefits, including potential anti-atherosclerotic effects. Analogues of resveratrol are chemically modified forms designed to improve bioavailability or potency. Preclinical studies (in vitro and in animal models) suggest that resveratrol and some analogues may inhibit vascular smooth muscle cell proliferation, reduce oxidative stress, and decrease inflammation—mechanisms relevant to arteriosclerosis development. Additionally, these compounds may improve endothelial function and reduce lipid accumulation in arterial walls.

However, robust clinical evidence in humans specifically for resveratrol analogues in arteriosclerosis is lacking. Most human data are limited to resveratrol itself, with small studies suggesting modest improvements in markers of vascular health, but results are inconsistent. No large-scale, long-term randomized controlled trials have confirmed that resveratrol analogues prevent or reverse arteriosclerosis in humans. Therefore, while their use is grounded in scientific inquiry and preclinical promise, the current evidence level is low, and these compounds are not established as standard therapy for arteriosclerosis.

More about Resveratrol analogue
More about Arteriosclerosis

Products containing Resveratrol analogue

We currently have no products on Caring Sunshine that contain this ingredient.